World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website http://www.wjon.org

Case Report

Volume 2, Number 3, June 2011, pages 143-146


Grade III Dermatitis in a Patient Treated With Paclitaxel and Radiotherapy: Case Report and Review of the Literature

Figure

Figure 1.
Figure 1. Grade III dermatitis after finishing the radiotherapy treatment.

Table

Table 1. Studies of Skin Toxicity From Concurrent Chemotherapy and Radiotherapy
 
StudiesCAPE dose (mg/m2 twice daily from days 1 to 14 every 3 weeks)Wpacli dose (mg/m2, days 1, 8 and 15)No. of patientsToxicity (Grade)
Di Constanzo F et al 2006 [4]12508031Grade IV: one patient
Unlmann C et al 2005 [5]10008015Reported generally
Gick U et al 2006 [6]8258055NR
Bari M et al 2005 [7]10006033Grade I/II: 15%
Blum JL et al 2006 [8]10008019NR (non reported)
Gradishar WJ et al 2004 [9]82517547NR
Kao J et al 2005 [12]-Dose escal.: 5 - 2033Grade II/IV: 8 patients
Burstein H et al 2006 [13]-Weekly: 60
Every 3 weeks: 135 - 175
40Grade II: 2 patients
Chen W et al 2010 [14]-17544Grade I: 77.8%
Grade II: 16.7%
Grade III: 5.6% (2 patients)
Hanna Y et al 2002 [15]-17520Grade II: 65% (13 patients)